Место фиксированной комбинации розувастатина и фенофибрата в лечении пациентов с комбинированной атерогенной дислипидемией

A. G. Obrezan; M. V. Ezhov; I. V. Sergienko; A. S. Alieva; V. S.  Gurevich

doi:10.34687/2219-8202.JAD.2022.01.0001

The place of a fixed combination of rosuvastatin and fenofibrate in the treatment of patients with combined atherogenic dyslipidemia

Authors

A. G. Obrezan
M. V. Ezhov
I. V. Sergienko
A. S. Alieva
V. S. Gurevich

DOI:

https://doi.org/10.34687/2219-8202.JAD.2022.01.0001

Abstract

Dyslipidemia forms the basis for the development and progression of atherosclerosis – a process that leads to the occurrence of a number of cardiovascular diseases and an increase in the total cardiovascular risk. Despite of significant progress in achieving control over atherosclerosis, patients often remain at a residual risk of developing adverse events. The article discusses the strategy of combined lipid-lowering therapy as a way to reduce the residual risk and achieve maximal benefit from therapeutic intervention.

Downloads

Download data is not yet available.

Downloads

PDF (Русский)

Published

2022-05-26

How to Cite

Obrezan A. G., Ezhov M. V., Sergienko I. V., Alieva A. S., Gurevich V. S. . The place of a fixed combination of rosuvastatin and fenofibrate in the treatment of patients with combined atherogenic dyslipidemia // The Journal of Atherosclerosis and Dyslipidemias. 2022. VOL. № 1 (46). PP. 5–23.

MLA
GOST

Download Citation

Issue

No. 1 (46) (2022)

Section

Review

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)

M. V. Ezhov, I. V. Sergienko, V. V. Kukharchuk, Clinical guidelines for lipid disorders 2023. What's new? , The Journal of Atherosclerosis and Dyslipidemias: No. 3 (52) (2023)
M. V. Ezhov, I. V. Sergienko, N. M. Akhmedzhanov, V. S. Gurevich, A. G. Obrezan, Dyslipidemia 2022 – how to reduce the risk and achieve the goal? , The Journal of Atherosclerosis and Dyslipidemias: No. 3 (48) (2022)
P. S. Sadovnikov, A. Yu. Olkhovik, V. S. Gurevich, Calculation method for the low-density lipoprotein cholesterol levels on the basis of the lipid metabolism modern paradigm , The Journal of Atherosclerosis and Dyslipidemias: No. 3 (48) (2022)
V. V. Kukharchuk, M. V. Ezhov, I. V. Sergienko, G. G. Arabidze, M. G. Bubnova, T. V. Balakhonova, V. S. Gurevich, M. A. Kachkovsky, G. A. Konovalov, V. O. Konstantinov, P. P. Malyshev , S. D. Pokrovsky, A. A. Sokolov, A. B. Sumarokov, N. B. Gornyakova, A. G. Obrezan, I. I. Shaposhnik, M. B. Antsiferov, A. A. Ansheles, D. M. Aronov, N. M. Akhmedzhanov, O. L. Barbarash , S. A. Boitsov, M. I. Voivoda, G. R. Galstyan, A. S. Galyavich, O. M. Drapkina, D. V. Duplyakov, S. Ya. Eregin, R. S. Karpov, Yu. A. Karpov, N. A. Koziolova, E. D. Kosmachev, D. V. Nebieridze, S. V. Nedogoda, V. E. Oleynikov, Yu. I. Ragino, V. V. Skibitsky, O. G. Smolenskaya, A. E. Filippov, Yu. Sh. Halimov, I. E. Chazova, M. V. Shestakova, S. S. Yakushin, Diagnostics and correction of lipid metabolism disorders in order to prevent and treat of atherosclerosis Russian recommendations VII revision. Moscow, 2020 , The Journal of Atherosclerosis and Dyslipidemias: No. 1 (38) (2020)
I. V. Sergienko, M. V. Ezhov, V. S. Gurevich, V. K. Zafiraki, P. A. Barov, O. V. Tsygankova, E. A. Tsyplenkova, E. P. Prikhodko, N. G. Vinogradova, V. R. Idiyatullina, E. V. Vyrupaeva, M. V. Savchenko, Yu. E. Yukhina, A. A. Kalinovskaya, E. S. Timoshchenko, A. A. Nekrasov, O. G. Smolenskaya, K. S. Manko, E. V. Timoshina, Comparative efficacy and safety of statin monotherapy and their combination with ezetimibe (Results of the Russian retrospective observational study UNISON) , The Journal of Atherosclerosis and Dyslipidemias: No. 4 (49) (2022)
U. V. Chubykina, M. V. Ezhov, T. A. Rozhkova , B. M. Tamaeva, A. A. Sokolov, A. I. Ershova, A. N Meshkov, V. I. Mikhailina, A. V. Blokhina, A. S. Limonova, O. V. Kopylova, I. I. Shaposhnik, V. V. Genkel , V. S. Gurevich, S. A. Urazgildeeva, A. V. Tregubov, M. V. Muzalevskaya, M. I. Voevoda, O. V. Timoshchenko, E. V. Shakhtshneider, Yu. I. Ragino, I. V. Leontyeva, L. V. Egorov, I. N. Zakharova, I.I. Pshenichnikova, D. I. Sadykova, E. S. Slastnikova, L. F. Galimova, E. D. Kosmacheva, A. M. Namitokov, A. S. Alieva, A. S. Galyavich, Z. F. Kim, V. A. Korneva, T. Yu. Kuznetsova, A. E. Filippov, A. M. Tuktarov, A. S. Vorobyov, I. D. Astrakhantseva, D. Yu. Bogdanov, M. A. Kachkovsky, A. V. Egorova, V. O. Konstantinov, M. P. Serebrenitskaya, V. K. Zafiraki, N. N. Bizyaeva, N. G. Androsyuk, M. A. Kiseleva, Yu. G. Grigorieva, O.Yu. Korennova, Yu. E. Yukhina, M. D. Devyatova, O. N. Ivanova, P. A. Vasiliev, I. V. Avdeeva, V. E. Oleinikov, Yu. A. Vorobieva, Yu. A. Ermakova, N. V. Mukha, D. N. Zaitsev, M. V. Zykov, A.V. Isaeva, T. I. Petelina, E. V. Mikova, A five-year follow-up period in homo- and heterozygous familial hypercholesterolemia patients of the RENAISSANCE registry , The Journal of Atherosclerosis and Dyslipidemias: No. 1(50) (2023)
M. V. Ezhov, S. S. Bazhan, A. I. Ershova, A. N. Meshkov, A. A. Sokolov, V. V. Kukharchuk, V. S. Gurevich, M. I. Voevoda, I. V. Sergienko, E. V. Shakhtshneider, S. N. Pokrovsky, G. A. Konovalov, I. V. Leontyeva, V. O. Konstantinov, M. Yu. Shcherbakova, I. N. Zakharova, T. V. Balakhonova, A. E. Filippov, N. M. Akhmedzhanov, O. Yu. Aleksandrova, B. M. Lipovetsky, Clinical guidelines for familial hypercholesterolemia , The Journal of Atherosclerosis and Dyslipidemias: No. 1 (34) (2019)
I. V. Sergienko, M. V. Shestakova, S. A. Boystov, A. S. Ametov, M. B. Antsiferov, V. V. Kukharchuk, D. A. Zateishchikov, M. V. Ezhov, V. S. Gurevich, A. S. Galyavich, M. I. Voevoda, D. V. Duplyakov, O. L. Barbarash, Yu. Sh. Khalimov, G. P. Arutyunov, Yu. A. Karpov, M. G. Bubnova, L. Yu. Drozdova, A. A. Ansheles, I. V. Samorodskaya, N. A. Koziolova, O. M. Drapkina, Extreme risk category in the stratification system cardiovascular complications , The Journal of Atherosclerosis and Dyslipidemias: No. 4 (33) (2018)
M. V. Ezhov, I. V. Sergienko, D. M. Aronov, G. G. Arabidze, N. M. Akhmedzhanov, S. S. Bazhan, T. V. Balakhonova, O. L. Barbarash, S. A. Boytsov, M. G. Бубнова Bubnova, M. I. Voevoda, A. S. Galyavich, N. B. Gornyakova, V. S. Gurevich, O. M. Drapkina, D. V. Duplyakov, S. Ya. Yeregin, M. Yu. Zubareva, R.S. Karpov, Yu. A. Karpov, N. A. Koziolova, G. A. Konovalov, V. O. Konstantinov, E. D. Kosmacheva, A. I. Martynov, D. V. Nebieridze, S. N. Pokrovsky, Yu. I. Ragino, V. V. Skibitsky, O. G. Smolenskaya, I. E. Chazova, S. A. Shalnova, I. I. Shaposhnik, V. V. Kukharchuk , Diagnostics and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis. Russian recommendations VI revision , The Journal of Atherosclerosis and Dyslipidemias: No. 3 (28) (2017)
I. V. Sergienko, A. A. Ansheles, S. A. Boytsov, Risk factors, lipid profile indicators and hypolipidemic therapy in patients of various categories of cardiovascular risk: the results of the Aterostop registry , The Journal of Atherosclerosis and Dyslipidemias: No. 2 (51) (2023)

1 2 3 4 5 6 7 8 > >>

The place of a fixed combination of rosuvastatin and fenofibrate in the treatment of patients with combined atherogenic dyslipidemia

Authors

DOI:

Abstract

Downloads

Downloads

Published

How to Cite

Issue

Section

License

Most read articles by the same author(s)

Language

Make a Submission

Information

Indexing

Editor-in-chief

Rating

Current Issue